Trial Profile
A phase II multicenter trial of RAD001 in patients with metastatic or recurrent sarcomas
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 May 2014
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Osteosarcoma; Soft tissue sarcoma
- Focus Therapeutic Use
- 18 Apr 2013 New trial record